Follow
Joseph B. Babigumira
Joseph B. Babigumira
Impact Health LLC
Verified email at impacthealth.global
Title
Cited by
Cited by
Year
Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial
P Piola, C Fogg, F Bajunirwe, S Biraro, F Grandesso, E Ruzagira, ...
The Lancet 365 (9469), 1467-1473, 2005
2522005
Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis
S Verguet, ZD Olson, JB Babigumira, D Desalegn, KA Johansson, ...
The Lancet Global Health 3 (5), e288-e296, 2015
1352015
Global eradication of measles: an epidemiologic and economic evaluation
A Levin, C Burgess, LP Garrison, C Bauch, J Babigumira, E Simons, ...
The Journal of infectious diseases 204 (suppl_1), S98-S106, 2011
1052011
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
F Checchi, P Piola, C Fogg, F Bajunirwe, S Biraro, F Grandesso, ...
Malaria journal 5, 1-8, 2006
812006
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
L Roth, D Bempong, JB Babigumira, S Banoo, E Cooke, D Jeffreys, ...
Globalization and Health 14, 1-12, 2018
762018
People living with HIV travel farther to access healthcare: a population‐based geographic analysis from rural Uganda
AN Akullian, A Mukose, GA Levine, JB Babigumira
African Journal of Reproduction and Gynaecological Endoscopy 19 (1), 2016
722016
Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda
JB Babigumira, B Castelnuovo, A Stergachis, A Kiragga, P Shaefer, ...
Plos one 6 (3), e18193, 2011
632011
Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda
SH Masters, R Burstein, B DeCenso, K Moore, A Haakenstad, G Ikilezi, ...
PloS one 9 (12), e114762, 2014
582014
Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
JB Babigumira, B Castelnuovo, M Lamorde, A Kambugu, A Stergachis, ...
BMC health services research 9, 1-6, 2009
582009
Telehealth for acute and chronic care consultations
AM Totten, RN Hansen, J Wagner, L Stillman, I Ivlev, C Davis-O’Reilly, ...
562019
Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda
JB Babigumira, AK Sethi, KA Smyth, ME Singer
Pharmacoeconomics 27, 963-973, 2009
552009
Health economics of rubella: a systematic review to assess the value of rubella vaccination
JB Babigumira, I Morgan, A Levin
BMC Public Health 13, 1-12, 2013
522013
Estimating the costs of induced abortion in Uganda: a model-based analysis
JB Babigumira, A Stergachis, DL Veenstra, JS Gardner, J Ngonzi, ...
BMC public health 11, 1-9, 2011
522011
Health technology assessment in low-and middle-income countries: a landscape assessment
JB Babigumira, AM Jenny, R Bartlein, A Stergachis, LP Garrison
Journal of Pharmaceutical Health Services Research 7 (1), 37-42, 2016
502016
Use of the Fogg behavior model to assess the impact of a social marketing campaign on condom use in Pakistan
S Agha, D Tollefson, S Paul, D Green, JB Babigumira
Journal of health communication 24 (3), 284-292, 2019
462019
Potential cost-effectiveness of universal access to modern contraceptives in Uganda
JB Babigumira, A Stergachis, DL Veenstra, JS Gardner, J Ngonzi, ...
PloS one 7 (2), e30735, 2012
402012
Cost-effectiveness analysis of pertuzumab with trastuzumab and chemotherapy compared to trastuzumab and chemotherapy in the adjuvant treatment of HER2-positive breast cancer in …
LP Garrison Jr, J Babigumira, C Tournier, HP Goertz, SJ Lubinga, ...
Value in health 22 (4), 408-415, 2019
372019
Assessing the potential cost‐effectiveness of retesting IHC0, IHC1+, or FISH‐negative early stage breast cancer patients for HER2 status
LP Garrison Jr, D Lalla, M Brammer, JB Babigumira, B Wang, EA Perez
Cancer 119 (17), 3113-3122, 2013
352013
The lifetime economic burden of inaccurate HER2 testing: estimating the costs of false-positive and false-negative HER2 test results in US patients with early-stage breast cancer
LP Garrison Jr, JB Babigumira, A Masaquel, BCM Wang, D Lalla, ...
Value in health 18 (4), 541-546, 2015
332015
Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial)
PB Pavlinac, BO Singa, GC John-Stewart, BA Richardson, RL Brander, ...
BMJ open 7 (12), e019170, 2017
292017
The system can't perform the operation now. Try again later.
Articles 1–20